Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

Budesonide

Unique Identifier:LOPAC 00729
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:C25H34O6
Molecular Weight:399.288 g/mol
X log p:4.048  (online calculus)
Lipinksi Failures0
TPSA52.6
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:6
Rotatable Bond Count:4
Canonical Smiles:CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO
Class:Hormone
Selectivity:Cortisol
Generic_name:Budesonide
Drug_type:Approved Drug
Pharmgkb_id:PA448681
Kegg_compound_id:C06858
Drugbank_id:APRD00442
Melting_point:221-232 oC
H2o_solubility:insoluble
Logp:3.145
Cas_registry_number:51333-22-3
Drug_category:Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06;
ATC:D07AC09; ATC:R01AD05; ATC:R03BA02
Indication:For the treatment of mild to moderate active Crohn-s disease.
Pharmacology:Budesonide is a synthetic corticosteroid indicated for the treatment of mild to
moderate active Crohn-s disease involving the ileum and/or the ascending colon.
Budesonide is used in Crohn-s disease to decrease the symptoms and inflammation
associated with the disease, especially at times of flare up. Budesonide has a high
topical glucocorticosteroid (GCS) activity and a substantial first pass elimination.
The formulation contains granules which are coated to protect dissolution in gastric
juice, but which dissolve at pH >5.5, ie, normally when the granules reach the
duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the
release of the drug into the intestinal lumen in a time-dependent manner.
Mechanism_of_action:The exact mechanism of action of budesonide in the treatment of Crohn-s disease is
not fully understood. However, being a glucocorticosteroid, budesonide has a high
local anti-inflammatory effect.
Organisms_affected:Humans and other mammals

Found: 24 nonactive as graph: single | with analogs 2 3 4 5 6 7 8 9 10  Next >> [24]
Species: 4932
Condition: BY4741
Replicates: 8
Raw OD Value: r im 0.7999±0.0935231
Normalized OD Score: sc h 0.9724±0.0361116
Z-Score: -0.8681±1.08501
p-Value: 0.444006
Z-Factor: -8.19604
Fitness Defect: 0.8119
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Lopac
Plate Number and Position:3|B5
Drug Concentration:50.00 nM
OD Absorbance:600 nm
Robot Temperature:27.60 Celcius
Date:2005-04-07 YYYY-MM-DD
Plate CH Control (+):0.045962499999999996±0.00136
Plate DMSO Control (-):0.7777812499999999±0.02984
Plate Z-Factor:0.8704
png
ps
pdf

DBLink | Rows returned: 132 3 Next >> 
2462
40000
63006
470826
3033890
5281004

internal high similarity DBLink | Rows returned: 1
SPE01500813 1.0000

nonactive | Cluster 17014 | Additional Members: 17 | Rows returned: 14<< Back 1 2 3
Prest404 0
SPE01500496 0

Service provided by the Mike Tyers Laboratory